Zealand Pharma - Transactions related to share buy-back program (week 27, 2026)

Zealand Pharma completed its share buy-back program for week 27 (June 29 - July 3, 2026), repurchasing 170,000 shares at an average price of DKK 282.64-301.67 per share, totaling DKK 49.86 million. The company has now accumulated 1,619,000 shares (3.47% of share capital) under its DKK 1.3 billion buy-back authorization, which runs through October 31, 2026.